May 22 (Reuters) - Sirtex Medical Ltd SRX.AX :
* ASX ALERT-SIRTEX RECEIVES BINDING OFFER FROM CDH-SRX.AX
* HAS RECEIVED OFFER CAPABLE OF ACCEPTANCE FROM CDH GENETECH LIMITED FOR ACQUISITION OF ALL OF SHARES IN SIRTEX
* BOARD OF SIRTEX IS CONSIDERING RELATIVE MERITS AND RISKS OF CDH PROPOSAL AND VARIAN SCHEME
* WORLDWIDE DOSE SALES FOR PERIOD 1 JANUARY TO 30 APRIL 2018 WERE 3,755, DOWN 10.6% VERSUS PCP
* NOW ANTICIPATES THAT FY18 UNDERLYING EBITDA WILL BE AT LOWER END OF $75-85 MILLION GUIDANCE PREVIOUSLY ISSUED
* DIRECTORS OF SIRTEX CONTINUE TO UNANIMOUSLY SUPPORT AND RECOMMEND VARIAN SCHEME
* SECOND HALF DOSE SALES ARE EXPECTED TO BE RELATIVELY FLAT VERSUS FIRST HALF